The Relationship between Various Obesity Indices and Level of Male Hormone according to Different Age Groups

Yoo-Jung Lee; Hyeon-Ju Kim; Mi-Hee Kong

Article

Korean J Obes 2014; 23(4): 245-249

Published online December 30, 2014

The Relationship between Various Obesity Indices and Level of Male Hormone according to Different Age Groups

Yoo-Jung Lee, Hyeon-Ju Kim, Mi-Hee Kong^*

Author Affiliations

Department of Family Medicine, School of Medicine, Jeju National University & Hospital, Jeju, Korea

Received: April 21, 2014; Reviewed : May 20, 2014; Accepted: August 4, 2014

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Go to

Abstract
Table
References

Background: The decrease in testosterone level during the aging process is associated with decrease in muscle mass and increase in visceral fat and body fat percent. The present study investigates the relationship between various obesity indices and level of testosterone according to different age groups. Methods: A total of 156 individuals who underwent specific health exams in a local university hospital from January 2011 to July 2013 were included. Obesity indices were represented as BMI, waist circumference (WC), body fat percent (BFP), visceral fat area (VFA), subcutaneous fat area (SFA), and visceral to subcutaneous ratio (VSR). Subjects were categorized into four age groups: 35-44 years, 45-54 years, 54-64 years, and over 65. Results: In almost all age groups obesity indices showed an inverse relation to testosterone level while VSR showed no significant association with either total or free testosterone levels. All obesity indices (BMI, WC, BFP, VFA, and SFA), except for VSR, manifested a statistically significant inverse correlation with total testosterone level, especially among subjects in the age group of 35-44 years and those greater than 65 years. However, free testosterone level failed to show a significant correlation with any of the obesity indices. No significant difference was noted in the correlation coefficient value among the different age groups. Conclusion: BMI and WC significantly increased in all age groups as total testosterone level decreased. Body fat percent, visceral fat area and subcutaneous fat area showed a significant inverse correlation with total testosterone in the relatively young aged subjects and in the old aged groups.

Keywords: Testosterone, Obesity index, Age

Tables

Go to

Abstract
Table
References

Basic obesity indices of the study population

Basic obesity indices according to age groups

Relationship between male hormone and obesity indices according to age groups

References

Go to

Abstract
Table
References

Rudman D, Drinka PJ, Wilson CR, Mattson DE, Scherman F, Cuisinier MC, et al. Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol (Oxf) 1994;40:653-61.
Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996;81:4358-65.
Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 2003;149:583-9.
Bose K. Age trends in adiposity and central body fat distribution among adult white men resident in Peterborough, East Anglia, England. Coll Anthropol 2002;26:179-86.
Kim KY, Kang IS, Kang YG, Kim SL, Sin KK, Kim MJ, et al. The relationship among testosterone, IGF-1 and fat mass. J Korean Acad Fam Med 2003;24:245-53.
Kwon KY, Han JH. Clinical significance of visceral adipose tissue. J Korean Acad Fam Med 2007;28:739-47.
Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, et al. Investigation, treatment, monitoring of lateonset hypogonadism in males: ISA, ISSAM, EAU recommendations. J Androl 2006;27:135-7.
Mudali S, Dobs AS. Effects of testosterone on body composition of the aging male. Mech Ageing Dev 2004;125:297-304.
Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril 2006;85:1319-40.
Laaksonen DE, Niskanen L, Punnonen K, Nyyss?nen K, Tuomainen TP, Salonen R, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003;149:601-8.
Laaksonen DE, Niskanen L, Punnonen K, Nyyss?nen K, Tuomainen TP, Valkonen VP, et al. Testosterone and sex hormonebinding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036-41.
Anawalt BD, Merriam GR. Neuroendocrine aging in men. Andropause and somatopause. Endocrinol Metab Clin North Am 2001;30:647-69.
Dayal M, Sammel MD, Zhao J, Hummel AC, Vandenbourne K, Barnhart KT. Supplementation with DHEA: effect on muscle size, strength, quality of life, lipids. J Womens Health (Larchmt) 2005;14:391-400.
Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 2004;151:1-14.
Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 2004;292:2243-8.
Hong ES, Kim SY, Choi YJ, Kim SW, Shin CS, Park KS, et al. The effects on visceral fat and cardiovascular risk factors of testosterone replacement in secondary hypogonadal men. J Korean Soc Endocrinol 2005;20:252-60.